<DOC>
	<DOCNO>NCT02186600</DOCNO>
	<brief_summary>The purpose study identify best way prevent bone loss first year menopause . The HOPE study compare bone loss 12 month woman : 1 ) take calcium vitamin D ; 2 ) take calcium vitamin D plus medication `` risedronate '' ; 3 ) take calcium vitamin D plus participate bone-loading exercise . Our central hypothesis improvement bone health great woman randomize bone-loading exercise calcium vitamin D compare woman take calcium vitamin D woman take calcium vitamin D plus risedronate .</brief_summary>
	<brief_title>Study Comparing Bone Loss Women Who Take Calcium Vitamin D With Women Who Also Take Risedronate Exercise</brief_title>
	<detailed_description>This randomize control trial ( RCT ) compare change 12 month bone structure , bone mineral density ( BMD ) , bone turnover woman low bone mass within 5 year menopause . Women randomize one control 2 treatment group ( n =103 per group ) : 1 ) optimal calcium + vitamin D ( optimal CaD ) alone ( Control ) ; 2 ) Bisphosphonate ( BP ) plus optimal CaD ( Risedronate ) ; 3 ) bone load exercise program plus optimal CaD ( Exercise ) . Our central hypothesis improvement bone health great subject randomize exercise group compare subject either control risedronate group . Specific Aims : Aims 1 , 2 , 3 compare control , risedronate , exercise group subject change bone structure tibia hip ( measure pQCT Hip Structural Analysis ) ( Aim 1 ) ; change BMD total hip , femoral neck , spine ( Aim 2 ) ; change serum marker bone formation resorption ( Aim 3 ) . In addition , Aim 4 explore relationship adherence exercise ( % session attend ) adherence risedronate ( % pills take ) change bone structure .</detailed_description>
	<mesh_term>Bone Diseases , Metabolic</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<mesh_term>Calcium , Dietary</mesh_term>
	<mesh_term>Risedronate Sodium</mesh_term>
	<mesh_term>Etidronic Acid</mesh_term>
	<mesh_term>Calcium Carbonate</mesh_term>
	<criteria>Women first 5 year menopause Have T score 1 2.49 femoral neck , total hip , L1L4 spine Be 19 year age old Have health care provider 's permission enroll study . Have osteoporosis Have 10 yr probability hip fracture &gt; 3 % major fracture &gt; 20 % base result FRAX tool Currently take bisphosphonates , estrogen replacement therapy , glucocorticosteroids , drug affect bone Currently participate resistance training high impact weight bear exercise program two time weekly Weigh &gt; 300 lb Have abnormal result follow laboratory test : serum 25 ( OH ) D ; serum creatinine ; serum calcium ; PTH ; TSH Have Paget 's disease , heart disease , uncontrolled hypertension , renal disease , concomitant condition prohibit participation exercise , risedronate therapy , use CaD supplement .</criteria>
	<gender>Female</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Low bone mass</keyword>
	<keyword>Post-menopausal woman</keyword>
	<keyword>Bone mineral density</keyword>
	<keyword>Bone structure</keyword>
	<keyword>Bone turnover</keyword>
	<keyword>Bone-loading exercise</keyword>
	<keyword>Optimal calcium vitamin D</keyword>
	<keyword>risedronate</keyword>
</DOC>